URL
https://clinicaltrials.gov/study/NCT07222215?term=CAPELA&rank=1
Dana-Farber/ Harvard Cancer Center
Long title
Phase II Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA)